Research and education
Clinical research with clear protocols and careful oversight
The Center for Regenerative Medicine participates in clinical research to study specific questions in musculoskeletal care. Research is kept distinct from routine patient care, and participation is considered only after an individual eligibility review.
Current registered study
Pilot study for facet-related back pain
ClinicalTrials.gov lists a Phase 1, open-label, dose-escalation pilot study evaluating the safety and tolerability of an investigational product delivered by facet-joint injection for adults with chronic facet-related back pain. The registry identifies The Center for Regenerative Medicine in North Miami as the study location.
The study is designed primarily to evaluate safety. Its investigational product is not presented as routine care, and registration does not establish that it is approved, effective, or appropriate for an individual patient.
View study record NCT05909709Patient safety
Research participation begins with informed consent, eligibility review, and a clear discussion of the study requirements and potential risks.
Defined protocols
Registered studies follow a written protocol with specified eligibility criteria, study procedures, follow-up, and outcome measures.
Individual eligibility
A registered study is not routine treatment, and not every person with the condition being studied will qualify to participate.